10-03-2023, 06:48

FDA Advisory Committee votes in favour of the clinical

U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX
Globe Newswire10-03-2023, 06:48
7-03-2023, 13:09

WISe.ART Allows Artist to Showcase Their NFT Collection of

WISe.ART Allows Artist to Showcase Their NFT Collection of Art Created by Artificial Intelligence Algorithms GENEVA /
Globe Newswire7-03-2023, 13:09
23-02-2023, 13:08

Roche launches two new antibodies to identify key clinical

Recent advances in cancer genomics have deepened the medical community’s understanding of the molecular alterations in
Globe Newswire23-02-2023, 13:08
21-02-2023, 13:07

Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical

KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling
Globe Newswire21-02-2023, 13:07
20-02-2023, 13:25

Novartis announces the appointment of the

Gilbert Ghostine, CEO of the Swiss multi-national fragrances business Firmenich appointed Chairman-Designate of the
Globe Newswire20-02-2023, 13:25
17-02-2023, 13:12

WISeKey Strengthens its North American Footprint by Signing

WISeKey Strengthens its North American Footprint by Signing a Partnership Agreement with Rep One, a Leading Sales
Globe Newswire17-02-2023, 13:12
17-02-2023, 11:07

SIKA EXCEEDED CHF 10 BILLION SALES MARK – RECORD EBIT

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA EXCEEDED CHF 10 BILLION
Globe Newswire17-02-2023, 11:07
16-02-2023, 02:09

WISeKey Semiconductors Expands its North American Footprint

WISeKey Semiconductors Expands its North American Footprint Through a Partnership with Impact Technical Sales, a
Globe Newswire16-02-2023, 02:09
14-02-2023, 13:17

WISeKey Announces the Development of WISe.Social, a New

WISeKey Announces the Development of WISe.Social, a New Authenticated Social Media Network Powered by WISeID Access to
Globe Newswire14-02-2023, 13:17
14-02-2023, 13:16

Basilea reports strong financial results 2022 based on

22% year-on-year increase of royalty income from antifungal Cresemba®Operating profit of CHF 18.5 million and net
Globe Newswire14-02-2023, 13:16
13-02-2023, 16:21

WISeKey Announces Public Filing of Registration Statement

WISeKey Announces Public Filing of Registration Statement Relating to Proposed Spin-off of its Semiconductor Business
Globe Newswire13-02-2023, 16:21
10-02-2023, 13:07

[Ad hoc announcement pursuant to Art. 53 LR] Transaction in

Basel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Roche Long Term Foundation
Globe Newswire10-02-2023, 13:07